Epicardial Ablation

Epicardial Ablation – Reaching from the Outer Surface of the Heart

Is “Treatment From the Outside, Not Inside the Heart” Possible?

When catheter ablation is mentioned, many people picture the following scenario: a thin catheter advanced through the groin reaches the inner surface of the heart, an abnormal electrical focus is identified, and ablation is performed. This description holds true for many rhythm disorders. However, in some cases, the abnormal electrical activity is not located on the inner surface of the heart, but on its outer surface—the epicardium. And reaching that outer surface requires a completely different technical approach.

Epicardial ablation is one of the most advanced techniques in cardiac electrophysiology. It stands out as a life-saving option, particularly in cases of refractory ventricular tachycardia. In this article, we will try to explain in clear terms how epicardial access is achieved, how VT ablation via this route is performed, why it is necessary, and what kind of results it yields.

The Layers of the Heart – Why the Outer Surface Matters?

You can think of the heart like an onion; it consists of multiple layers. The innermost layer is the endocardium; this is the thin lining covering the inner surface of the heart that we reach when advancing the catheter from the groin. The middle layer is the myocardium; all of the heart’s muscle tissue is located here. The outermost layer is the epicardium, a thin membrane wrapping around the heart muscle from the outside.

Overlying the epicardium is the pericardium, a two-layered sac surrounding the heart. Between these two layers—the visceral pericardium and the parietal pericardium—there is normally a narrow space containing a very small amount of fluid. This space—the pericardial space—is where epicardial ablation is performed.

In some VT cases, the critical point of the abnormal electrical circuit is located in the outer layer of the myocardium or the epicardium. Ablation performed from the endocardium cannot reach this point because when the muscle layer is thick, the energy cannot penetrate deeply. In these patients, it is necessary to enter the pericardial space and place the catheter directly onto the epicardial surface.

Which Patients Require Epicardial Ablation?

Not every VT case requires epicardial ablation. However, in certain disease groups, the distribution of scar tissue is not limited to the endocardial surface; fibrosis extends to the middle layers of the myocardium or even the epicardium. In such cases, endocardial ablation falls short.

Nonischemic dilated cardiomyopathy is the disease group where epicardial ablation is most commonly performed. In these patients, fibrosis is predominantly concentrated in the basolateral left ventricular region and the middle to outer layers of the myocardium. Scars may not be visible on endocardial mapping; however, a large scar area is detected on the epicardial surface. In a significant portion of these patients, endocardial ablation alone is ineffective, and lasting success cannot be achieved without an epicardial approach.

Arrhythmogenic right ventricular cardiomyopathy — ARVC is another condition where epicardial ablation plays a critical role. In ARVC, fatty and fibrous transformation begins on the epicardial surface of the right ventricle and progresses inward. Therefore, a major portion of the scar is located in the epicardium, and the critical channels of the VT circuit are mostly found on this outer surface.

Chagas disease cardiomyopathy is also a condition where epicardial ablation is widely applied. This parasitic infection-related cardiomyopathy, commonly seen in Latin American patients, creates characteristic epicardial scar areas in the inferior and posterolateral walls of the left ventricle.

Post-myocarditis VT, cardiac sarcoidosis, and certain hypertrophic cardiomyopathy cases can also present with outwardly localized scarring, bringing epicardial ablation into consideration.

In repeat — redo — VT ablation cases, where endocardial ablation was previously performed but VT recurred, an epicardial approach is frequently introduced as an additional strategy.

Epicardial Mapping in an ARVD Patient – ILAM Map

Endocardial Ventricular Tachycardia Ablation in a Hypertrophic Cardiomyopathy Patient.

How Is Epicardial Access Achieved? — Pericardial Puncture

The most critical and technically demanding step of epicardial ablation is safely entering the pericardial space. This procedure is called percutaneous subxiphoid pericardial puncture; meaning, without opening the rib cage, the outer layers of the heart sac are reached using only a needle.

Patient Preparation

The procedure is performed under general anesthesia or deep sedation because both the ablation and pericardial puncture phases require precision and immobility. The patient is placed in a supine position. Anticoagulation status is carefully evaluated; active anticoagulant use is managed prior to puncture. Fluoroscopy and echocardiography equipment are kept ready.

How Is the Puncture Performed?

A small incision is made in the skin just beneath the breastbone—below the xiphoid process. A specialized, small-angled needle is advanced subcutaneously from this area. The needle is guided with careful steps in front of the diaphragm toward the parietal pericardial layer, which forms the exterior of the pericardial sac.

This advancement is guided by two main methods. Fluoroscopy—X-ray imaging—continuously shows the position and direction of the needle relative to the heart shadow. Meanwhile, the location of the needle tip is monitored using a small amount of contrast agent injected into the needle or via real-time echocardiography.

When the needle tip enters the pericardial space, a change in pressure is felt, the contrast agent spreads freely within the pericardial space, or it is observed inside the space on echocardiography. This verification is critically important because unintentional entry of the needle into the heart cavity or a coronary vessel can lead to serious complications.

Once entry into the pericardial space is verified, a thin guidewire is advanced through the needle. After positioning the wire in the pericardial space, the needle is withdrawn, and a sheath is introduced over the wire. This sheath creates a safe entry channel for the epicardial ablation catheter.

Dry or Wet Pericardial Space?

A normal pericardial space contains a very small amount of fluid—this is a “dry” space. In patients who have previously had pericarditis, heart surgery, or ablation, this space may be filled with adhesions. In this case, the catheter cannot move freely, and the quality of mapping decreases. The presence of adhesions significantly complicates epicardial ablation technically and can sometimes prevent the approach from being completed safely. Therefore, epicardial access requires much more careful evaluation in patients with prior heart surgery.

Epicardial Mapping and Peak Frequency in an ARVD Patient

Epicardial Ventricular Tachycardia Ablation in a Hypertrophic Cardiomyopathy Patient

Epicardial Mapping and Ablation – Step by Step

Once the pericardial space is safely entered, the ablation phase of the procedure begins. Although this phase shares many similarities with endocardial ablation, it involves distinct technical nuances.

Creation of the Three-Dimensional Epicardial Map

The mapping catheter introduced through the sheath can move freely within the pericardial space. A three-dimensional electroanatomical mapping system—platforms such as CARTO, EnSite, or Rhythmia—creates an anatomical and electrical map of the heart’s outer surface using this catheter.

On the epicardial map, the following parameters are particularly evaluated: the voltage map identifies scar areas and healthy tissue. The activation map shows the sequential propagation order of the electrical signal; critical channels of the VT circuit are identified on this map. Late potentials and fractionated signals point to slow conduction pathways of the circuit.

In most cases, endocardial and epicardial mapping are performed simultaneously. The endocardial catheter scans the inner surface of the heart, while the epicardial catheter scans the outer surface. Thanks to this dual-side mapping, the exact three-dimensional distribution of the scar and the precise pathway of the circuit are revealed with millimetric precision.

Induction and Mapping of VT

Whenever possible, VT is induced using electrophysiological stimulation protocols. Activation mapping performed while the VT is active shows the direction in which the circuit is propagating and the exact location of the critical gateway. Once the critical isthmus—the narrowest and slowest transition point of the circuit—is identified, this spot becomes the ablation target.

In some patients, VT is hemodynamically poorly tolerated; in this case, the substrate mapping method is used. Without inducing VT, scar areas and late potentials are mapped in normal rhythm; potential circuit pathways are estimated in light of this data, and a comprehensive substrate ablation is performed.

Delivery of Ablation Energy

After identifying the critical points, the ablation catheter is directed to these regions. Radiofrequency energy is the most frequently used method in epicardial ablation; however, there are some important differences on the epicardial surface.

Unlike the endocardium, the epicardium is covered with adipose tissue, and this fat layer impedes heat conduction. This condition can reduce the effectiveness of epicardial ablation; in areas with a thick fat layer, the lesion may fail to reach sufficient depth. To overcome this issue, some centers apply longer durations and higher energy; in some cases, ethanol—alcohol-based ablation or different energy modes may be used.

During the ablation procedure, a critical anatomical hazard is always kept in mind: the coronary arteries. Coronary vessels run along the epicardial surface, carrying a risk of direct contact with the ablation catheter. Therefore, prior to ablation, coronary angiography is performed, or angiographic images are integrated into the mapping system to evaluate the distance of the ablation points from the coronary vessels. As a general rule, ablation is avoided in areas closer than five millimeters to a coronary artery.

Similarly, the phrenic nerve—the nerve controlling the diaphragm—may run along the epicardial surface. Because phrenic nerve injury can adversely affect breathing, the location of the nerve is identified via stimulation prior to ablation.

Epicardial Mapping Activation Mapping in an ARVD Patient

Endo-Epicardial Ventricular Tachycardia Mapping in a Hypertrophic Cardiomyopathy Patient

Advantages of Epicardial Ablation

Although epicardial access is a challenging technique, when applied for the correct indication, it offers distinct advantages compared to endocardial ablation.

In patients heavily burdened with epicardial scars, such as nonischemic cardiomyopathy and ARVC, it becomes possible to directly reach circuit points where endocardial ablation falls short. A combined—endocardial and epicardial together—approach provides significantly better results in the vast majority of these patients compared to a single-sided approach.

In cases of recurrence following a previously failed endocardial ablation, the epicardial approach offers a new chance; regions that could not be reached during the initial ablation can be targeted.

In certain special VT foci—papillary muscle, near the mitral annular region, left ventricular apex—the epicardial side may provide a better ablation angle.

What Are the Success Rates?

The success of epicardial ablation varies significantly depending on the underlying disease, the extent of the scar, left ventricular function, and the technical quality of the procedure.

In VT caused by nonischemic dilated cardiomyopathy, a combined endocardial and epicardial approach can achieve a marked reduction or complete suppression of VT episodes in 60 to 80 percent of patients. Compared to series where endocardial ablation is performed alone, the addition of epicardial access significantly increases success rates.

In VT caused by ARVC, epicardial ablation plays a highly critical role. Success rates ranging between 70 and 85 percent are reported in experienced center series where epicardial substrate ablation is performed.

In VT caused by Chagas cardiomyopathy, epicardial ablation is an integral part of the standard approach; success rates of 65 to 80 percent are achieved with a combined approach.

As a general rule, it should be noted that epicardial ablation, unlike idiopathic VT ablation, is a procedure performed on a complex substrate background. Recurrence is possible in the long term, and ICD protection is maintained in some patients. However, successful ablation significantly improves quality of life by markedly reducing the VT burden, ICD shock frequency, and hospital admissions.

Epicardial Mapping Ablation in an ARVD Patient

Potential Complications – Risks to Know

Epicardial ablation is a procedure that requires experience and equipment, with a complication profile that is different and more complex than endocardial ablation. Therefore, it should only be performed in centers and by teams experienced in this field.

Pericardial tamponade is the most serious and frequent complication. When bleeding occurs during puncture of the pericardial space or during ablation, this fluid can accumulate rapidly and cause external compression of the heart. This condition requires emergency intervention—pericardial drainage. In experienced centers, tamponade rates are reported to range from two to five percent.

Inadvertent heart puncture: During epicardial access, it is possible for the needle to enter the heart cavity. In this case, the procedure is not continued; the needle is withdrawn, and the patient is placed under observation. In most cases, it closes on its own; however, if bleeding persists, intervention may be required.

Coronary artery injury: If a lesion is created too close to a coronary artery during ablation, vascular injury can develop. To prevent this risk, angiographic guidance and safe distance rules are meticulously applied.

Phrenic nerve paralysis: Ablation applications close to the phrenic nerve can lead to temporary or permanent phrenic nerve injury. To minimize this risk, the location of the nerve is predetermined.

Adhesion formation on the epicardial surface: A mild inflammatory response may develop in the pericardium following ablation. Over time, this condition can turn into small adhesions, potentially complicating any future epicardial access. Therefore, anti-inflammatory drugs such as steroids and colchicine can be administered into the pericardial space at the end of the procedure.

Long procedure duration: Epicardial ablation significantly extends the total procedure time due to the mapping and ablation phases added to endocardial ablation. Procedure durations reaching four to eight hours are not unusual in these cases.

Operating Room or Laboratory?

Epicardial ablation is not open-heart surgery. The rib cage is not opened, and a general surgery team is not required. The procedure is performed in the electrophysiology laboratory by a specially equipped team. However, it is mandatory to be prepared for potential emergency complications; therefore, cardiovascular surgery support must be accessible at all times in centers performing epicardial ablation.

In very rare situations—especially in the presence of dense adhesions or uncontrollable bleeding—conversion to surgery may be necessary. The patient is informed of this situation in advance, and consent is obtained.

Post-Ablation Process

When epicardial ablation is completed, a pericardial drainage catheter is left in place for a few hours before the pericardial sheath is withdrawn. Potential bleeding is monitored during this period; if the fluid volume is below the limits considered safe, the catheter is removed, and the patient is placed under observation.

A hospital stay of a few days post-procedure is generally necessary. Mild symptoms of pericardial inflammation—chest pain, fever—may be observed; these are controlled with anti-inflammatory treatment. Continuing colchicine treatment for a few weeks is recommended for pericarditis prophylaxis.

Anticoagulant therapy management is planned individually; device checks are performed in patients with an ICD. Rhythm and heart functions are evaluated with Holter, ECG, and echocardiography at the first- and third-month follow-ups.

Can This Procedure Be Performed in Every Center?

No. Epicardial ablation can only be performed in electrophysiology centers with specialized experience in this field. Being able to safely apply the pericardial puncture technique, interpret epicardial mapping, effectively perform epicardial substrate ablation, and rapidly manage potential complications requires a substantial accumulation of institutional and individual experience.

It has been consistently demonstrated in the literature that centers with a high annual case volume have both lower complication rates and higher success rates. Therefore, it is of great importance that patients who are candidates for epicardial ablation are referred to an experienced reference center.

Conclusion

Epicardial ablation is a challenging yet extremely valuable technical approach that enables access from the outer surface of the heart. In nonischemic cardiomyopathy, ARVC, Chagas disease, and many other conditions where the endocardial route falls short, epicardial access becomes the keystone of treatment. Ranging from the pericardial puncture phase to comprehensive mapping and targeted ablation, this process is one of the most complex and satisfying applications of modern electrophysiology, requiring the combination of experience, teamwork, and advanced technology.

Whether epicardial ablation should be considered in patients diagnosed with refractory VT, who have undergone prior ablation, or who have structural heart disease should be determined through a comprehensive electrophysiological evaluation and a detailed discussion with an experienced team.

This content is intended for general informational purposes only. Diagnostic and treatment decisions must be individually evaluated by a specialist cardiologist.

All Electrophysiology and Arrhythmia Treatments

Book an Appointment!

TR|EN